REFRACTORY APLASTIC ANEMIA

Clinical trials for REFRACTORY APLASTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY APLASTIC ANEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

New hope for bone marrow failure patients as experimental drug trial begins

Disease control Not yet recruiting

This study is testing whether adding a new drug called a JAK1 inhibitor to standard immune-suppressing therapy can help people with severe aplastic anemia. The trial has two parts: first testing safety in patients whose disease hasn't responded to standard treatment, then testing…

Matched conditions: REFRACTORY APLASTIC ANEMIA

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

REFRACTORY APLASTIC ANEMIA

Get alerted when new REFRACTORY APLASTIC ANEMIA trials appear

New hope for bone marrow failure patients as experimental drug trial begins